Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial. [electronic resource]
Producer: 20150219Description: 158 p. digitalISSN:- 1745-6215
- Attitude of Health Personnel
- Biomarkers -- blood
- Cardiovascular Diseases -- diagnosis
- Clinical Protocols
- Double-Blind Method
- Early Diagnosis
- England
- General Practitioners -- psychology
- Health Knowledge, Attitudes, Practice
- Humans
- Hyperkalemia -- blood
- Kidney Failure, Chronic -- complications
- Mineralocorticoid Receptor Antagonists -- adverse effects
- Pilot Projects
- Potassium -- blood
- Predictive Value of Tests
- Primary Health Care
- Prospective Studies
- Pulse Wave Analysis
- Qualitative Research
- Research Design
- Spironolactone -- adverse effects
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
- Vascular Stiffness -- drug effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.